NSN 6505-01-138-4751 of Atenolol Tablets Us - Parts Details
| Alternative NSN: 6505011384751 |
| Item Name: Atenolol Tablets Us |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 011384751 |
| NCB Code: USA (01) |
| Manufacturers: Mutual Pharmaceutical Company Inc , Sandoz Inc , Danbury Pharmacal Inc , Watson Pharmaceuticals Inc , Mylan Pharmaceuticals Inc , Astra Pharmaceuticals Lp , Astrazeneca Limited Partnership , Lemmon Co , Teva Pharmaceuticals Usa Inc |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC53489-0530-01, NDC00781-1507-01, NDC00591-5778-01, NDC00378-0757-01, NDC00310-0101-10 under NSN 6505-01-138-4751 of Atenolol Tablets Us manufactured by Mutual Pharmaceutical Company Inc, Sandoz Inc, Danbury Pharmacal Inc, Watson Pharmaceuticals Inc, Mylan Pharmaceuticals Inc.
Federal Supply Class of NSN 6505-01-138-4751 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-138-4751, 6505011384751
-
Part No Manufacturer Item Name QTY RFQ NDC53489-0530-01 Mutual Pharmaceutical Company Inc atenolol tablets us Avl RFQ NDC00781-1507-01 Sandoz Inc atenolol tablets us Avl RFQ NDC00591-5778-01 Danbury Pharmacal Inc atenolol tablets us Avl RFQ NDC00591-5778-01 Watson Pharmaceuticals Inc atenolol tablets us Avl RFQ NDC00378-0757-01 Mylan Pharmaceuticals Inc atenolol tablets us Avl RFQ NDC00310-0101-10 Astra Pharmaceuticals Lp atenolol tablets us Avl RFQ NDC00310-0010-11 Astrazeneca Limited Partnership atenolol tablets us Avl RFQ NDC00093-0753-01 Lemmon Co atenolol tablets us Avl RFQ NDC00093-0753-01 Teva Pharmaceuticals Usa Inc atenolol tablets us Avl RFQ
Characteristics Data of NSN 6505011384751MRC Criteria Characteristic AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 100.000 MILLIGRAMS ATENOLOL ACTIVE INGREDIENT CQCT PRIMARY CONTAINER TYPE BOTTLE CRLK PRIMARY CONTAINER CONTENT QUANTITY 100.000 TABLETS CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY ATENOLOL TABLETS 100MG 100S BT MDES MEDICAL DESIGNATION AND GRADE UNITED STATES PHARMACOPEIA
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS ATENOLOL ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | ATENOLOL TABLETS 100MG 100S BT |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |